Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
28.39
-0.37 (-1.29%)
Oct 30, 2026, 4:00 PM EST - Market closed
Zenas BioPharma Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Zenas BioPharma stock has a consensus rating of "Strong Buy" and an average price target of $47.88. The average 1-year stock price forecast is 68.65% higher than the current stock price, while the lowest is $32 (+12.72%) and the highest is $59 (+107.82%).
Price Target: $47.88 (+68.65%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Zenas BioPharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $48 | Buy | Maintains | $48 | +69.07% | Oct 28, 2026 |
| Morgan Stanley No rating | Morgan Stanley | Hold Maintains $32 | Hold | Maintains | $32 | +12.72% | Oct 28, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $55 | Buy | Reiterates | $55 | +93.73% | Oct 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $44 | Buy | Reiterates | $44 | +54.98% | Oct 28, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $45 | Buy | Maintains | $45 | +58.51% | Oct 13, 2026 |
Financial Forecast
Revenue This Year
12.26M
from 10.00M
Increased by 22.60%
Revenue Next Year
57.93M
from 12.26M
Increased by 372.53%
EPS This Year
-5.62
from -4.83
EPS Next Year
-4.66
from -5.62
EPS and Forward PE are based on non-GAAP adjusted numbers.